Embecta (EMBC) Total Current Liabilities (2021 - 2026)
Embecta's (EMBC) quarterly Total Current Liabilities came in at $247.3 million in Q1 2026, down 4.63% year-on-year from $259.3 million in Q1 2025, and up 5.37% quarter-over-quarter from $234.7 million in Q4 2025.
Embecta (EMBC) Total Current Liabilities (2021 - 2026) Analysis & Trends
Embecta has disclosed Total Current Liabilities across 6 years of filings, most recently posting $247.3 million for Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $247.3 million, down 4.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $247.3 million (down 4.63% YoY), and the FY2025 annual result was $261.5 million, down 30.08% from the prior year.
- Total Current Liabilities came in at $247.3 million for Q1 2026 at Embecta, up from $234.7 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $385.8 million in Q2 2023 to a low of $168.9 million in Q1 2022.
- The 5-year median for Total Current Liabilities is $301.0 million (2022), against an average of $301.4 million.
- Across the five-year window, Total Current Liabilities surged 132.75% in 2022 and slumped 30.08% in 2025, its largest moves.
- Embecta's Total Current Liabilities stood at $370.3 million in 2022, then slipped by 11.8% to $326.6 million in 2023, then dropped by 8.7% to $298.2 million in 2024, then dropped by 21.29% to $234.7 million in 2025, then increased by 5.37% to $247.3 million in 2026.
- The last three Total Current Liabilities figures came in at $247.3 million (Q1 2026), $234.7 million (Q4 2025), and $261.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 1.91 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 8.51 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 2.54 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 1.35 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 674.00 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 3.35 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 1.80 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.91 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 3.69 Bn |
| 10 | Embecta | 183.23 Mn | -10.17 Mn | 127.80 Mn | 247.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 247.30 Mn |
| Dec 31, 2025 | 234.70 Mn |
| Sep 30, 2025 | 261.50 Mn |
| Jun 30, 2025 | 275.50 Mn |
| Mar 31, 2025 | 259.30 Mn |
| Dec 31, 2024 | 298.20 Mn |
| Sep 30, 2024 | 374.00 Mn |
| Jun 30, 2024 | 370.70 Mn |
| Mar 31, 2024 | 310.40 Mn |
| Dec 31, 2023 | 326.60 Mn |
| Sep 30, 2023 | 353.50 Mn |
| Jun 30, 2023 | 385.80 Mn |
| Mar 31, 2023 | 357.70 Mn |
| Dec 31, 2022 | 370.30 Mn |
| Sep 30, 2022 | 301.00 Mn |
| Jun 30, 2022 | 228.50 Mn |
| Mar 31, 2022 | 168.90 Mn |
| Dec 31, 2021 | 159.10 Mn |
| Sep 30, 2021 | 164.00 Mn |